1. Bowen, A.C., Tong S.Y.C., Andrews, R.M., O’Meara, I.M, McDonald, M.I., Chatfield, M.D., Currie B.J., & Carapetis, J.R. (2014). Short course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. The Lancet, early online publication 27 August 2014. doi:10.1016/S0140-6736(14)60841-2
  2. Bowen, A.C., Lilliebridge, R.A., Tong, S.Y., Baird, R.W., Ward, P., McDonald, M.I., et al. (2012). Is Streptococcus pyogenes Resistant or Susceptible to Trimethoprim-Sulfamethoxazole? Journal of Clinical Microbiology, 50(12),4067-72.
  3. Bowen, A.C., Tong, S.Y., Carapetis, J.R. (2013). Reply to "Susceptibility of Streptococcus pyogenes to trimethoprim-sulfamethoxazole". Journal of Clinical Microbiology, 51(4),1351.
  4. Bowen, A.C., Tong, S.Y., Chatfield, M.D., Andrews, R.M., Carapetis, J.R. (2013). Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia. Royal Society of Tropical Medicine and Hygiene, 107(6), 384-9.
  5. Tong, S.Y., Andrews, R.M., Kearns, T., Gundjirryirr, R., McDonald, M.I., Currie, .B.J, et al. (2010). Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: a pilot randomised controlled trial. Journal of Paediatrics and Child Health, 46(3),131-3.